Targeted Drug Plus Hormone Therapy Stops Tumor Growth In Patients With Early Breast Cancer
A new clinical trial conducted in patients in the U.S., U.K., and Canada has shown that the addition of a targeted therapy drug to existing hormone treatment, greatly slows cancer cell growth in women with early-stage breast cancer.